The New Horizons Forum will take place on February 3rd at San Francisco’s iconic Westin St. Francis Hotel.
26-Jan-2023 6:50 PM EST Add to Favorites
Glaucoma Research Foundation to recognize leadership in glaucoma innovation and patient care at Annual Gala in San Francisco
GRF's leadership awards will be presented at the Glaucoma 360 Annual Gala on February 2, 2023 at the iconic Westin St. Francis Hotel in San Francisco.
26-Jan-2023 6:35 PM EST Add to Favorites
Santen will receive GRF’s highest honor, the Catalyst Award, at the Glaucoma 360 Annual Gala on February 2, 2023, in San Francisco.
26-Jan-2023 6:25 PM EST Add to Favorites
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
Bausch + Lomb, a leading global eye health company, and Glaucoma Research Foundation a non-profit organization with the vision of curing glaucoma, today announced the launch of ‘Screen, Protect, Cure,’ a campaign designed to provide educational...
3-Jan-2023 6:35 PM EST Add to Favorites
The findings from the meeting were recently published in Molecular Neurodegeneration and raise opportunities for new treatments and cures for neurodegenerative diseases like glaucoma and Alzheimer’s.
11-Aug-2022 1:35 PM EDT Add to Favorites
Glaucoma Research Foundation Launches Catalyst For A Cure Initiative to Prevent and Cure Neurodegeneration
The Neurodegeneration Initiative was launched through a transformative $2.4 million gift to Glaucoma Research Foundation from the Melza M. and Frank Theodore Barr Foundation.
15-Jul-2022 1:50 PM EDT Add to Favorites
Glaucoma Research Foundation (GRF) today announced a total of $1.3 million in annual research grants to support 10 investigators at prominent universities across the United States.
9-Mar-2022 4:05 PM EST Add to Favorites
Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, recently elected Oluwatosin “Tosin” Smith, MD to its Board of Directors.
9-Mar-2022 1:55 PM EST Add to Favorites
See All News
At present, the only FDA approved method of treating glaucoma is to lower eye pressure; this slows the progression of glaucomatous optic nerve damage but does not completely halt it, and certainly does not regenerate damaged nerve tissue.
16-Jun-2017 11:45 AM EDT
Stem cells may have the potential to protect the optic nerve from further damage and slow the progression of vision loss due to glaucoma. Stem cells may also have the potential to replace ocular tissues that have degenerated in eyes with glaucoma.
17-Mar-2016 9:05 AM EDT